Amicus Therapeutics
Price & Volume
Stats
See more52W Range | $6.20-$12.65 |
Market Cap | $2B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $528.2M |
Revenue Growth (YoY) | 30.1% |
Gross Profit (12 Mos) | $475.3M |
Diluted EPS | -$0.18 |
News
See moreYahoo Finance • 3 days ago
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
Yahoo Finance • 10 days ago
Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
Yahoo Finance • 12 days ago
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
Yahoo Finance • 25 days ago
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires?
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 499 |
